Global_Molecular_Diagnostics_Market
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> - <strong>Global</strong><br />
Industry Analysis, Size, Share, Growth,<br />
Trends and Forecast, 2017 - 2025<br />
The global molecular diagnostics market is highly consolidated<br />
in nature, observes Transparency <strong>Market</strong> Research. The leading<br />
players accounted for a share of 54% in the overall market in<br />
2015. F. Hoffman-La Roche Ltd., Abbott Laboratories, and<br />
Danaher Corporation have dominated the global market in the<br />
past few years.<br />
The broad product portfolio and strategic mergers and<br />
acquisitions have been the winning strategies of these players to<br />
remain dominant.<br />
According to the research report, the global molecular<br />
diagnostic market is estimated to reach a valuation of US$18.9<br />
bn by the end of 2025 as compared to US$7.1 bn in 2016.<br />
Between the forecast years of 2016 and 2025, the global market<br />
is estimated to expand at a steady CAGR of 11.6%.<br />
On the basis of technology, the global molecular diagnostics<br />
market is segmented into PCR and real-time PCR, hybridization,<br />
microarray, transcription-mediated amplification, nextgeneration<br />
sequencing, and others such as mass spectrometry. Of<br />
these, the PCR and real-time PCR technology segment is
anticipated to show a significant progress during the forecast<br />
years. This segment is projected to expand at a CAGR of 11.1%<br />
between 2016 and 2025. The extensive usage of this technology<br />
is expected to play significant role in its growth.<br />
Browse Full Research Report on <strong>Molecular</strong> <strong>Diagnostics</strong><br />
<strong>Market</strong>:<br />
http://www.transparencymarketresearch.com/moleculardiagnostics-industry.html<br />
On the basis of geography, the global molecular diagnostics<br />
market is segmented into North America, Europe, Asia Pacific,<br />
the Middle East and Africa, and Latin America. Of these, North<br />
America is estimated to account for a share of 39.6% in the<br />
overall market by the end of 2025. This segment is likely to<br />
thrive due to the changing demographics, high prevalence of<br />
cancer, evolving lifestyles, and well-established healthcare<br />
infrastructure.<br />
The global molecular diagnostic market is anticipated to be<br />
driven by the growing investments in research and development<br />
of biomarkers. The increasing uptake of biomarkers for<br />
diagnosis and prognosis as well as prediction and assessment of<br />
ongoing has augmented the demand for molecular diagnostics.
Several kits designed for molecular diagnostics allow safe,<br />
quick, and accurate detection of infectious diseases such as HIV<br />
and hepatitis. Thus, the growing interest of big companies in<br />
expanding their business through developing biomarker<br />
solutions is expected to benefit the overall market.<br />
The continuous evolution in the field of molecular biology has<br />
changed the way diseases are being diagnosed and treated. The<br />
new methods have the ability to detect bacteria, viruses, and<br />
genetic variations in less time in with absolute precision.<br />
Thus, the upgrades in technology, which have significantly<br />
customized health care have boosted the demand for molecular<br />
diagnostics in recent years. Analysts also predict that the wide<br />
range of technologies for diagnosis of diseases will give the<br />
global market a shot in the arm during the forecast period.<br />
The long lead time for FDA approvals for molecular diagnostics<br />
is severely restraining the growth of the global market.<br />
<strong>Molecular</strong> diagnostics haven’t had a clinical impact on medical<br />
practice as was predicted earlier as delays in approvals have<br />
created potential hurdles.
The market is also being hampered due to the poor<br />
reimbursement policies. The low awareness and lack of clarity<br />
pertaining to the diagnostic techniques used for detecting<br />
various injections and chronic conditions is a key challenge to<br />
the growth of the overall market.<br />
This review is based on Transparency <strong>Market</strong> Research, titled<br />
“<strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> - <strong>Global</strong> Industry Analysis, Size,<br />
Share, Growth, Trends and Forecast, 2017-2025.”<br />
Browse Full Press Release on Heparin <strong>Market</strong>:<br />
Press Release<br />
About Us<br />
Transparency <strong>Market</strong> Research (TMR) is a global market<br />
intelligence company providing business information reports<br />
and services. The company’s exclusive blend of quantitative<br />
forecasting and trend analysis provides forward-looking insight<br />
for thousands of decision makers. TMR’s experienced team of<br />
analysts, researchers, and consultants use proprietary data<br />
sources and various tools and techniques to gather and analyze<br />
information.<br />
TMR’s data repository is continuously updated and revised by a<br />
team of research experts so that it always reflects the latest
trends and information. With extensive research and analysis<br />
capabilities, Transparency <strong>Market</strong> Research employs rigorous<br />
primary and secondary research techniques to develop<br />
distinctive data sets and research material for business reports.<br />
Contact Us<br />
Transparency <strong>Market</strong> Research<br />
State Tower,<br />
90 State Street, Suite 700,<br />
Albany NY - 12207<br />
United States<br />
USA - Canada Toll Free: 866-552-3453<br />
Email: sales@transparencymarketresearch.com<br />
Website: http://www.transparencymarketresearch.com
Change language